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Abstract
Background/Aims: Cardiac changes observed in chronic kidney disease patients are of 
multifactorial origin including chronic uremia, hemodynamics or inflammation. Restoration 
of renal function by kidney transplantation (KTX) may reverse cardiac changes. Novel 
echocardiographic methods such as speckle tracking echocardiography (STE) allow early and 
sensitive detection of subtle changes of cardiac parameters. We evaluated changes of cardiac 
structure and function after KTX by advanced echocardiographic modalities. Methods: Thirty-
one KTX recipients (female n=11) were evaluated by medical examination, laboratory testing 
and echocardiography before and after KTX (median follow-up 19 months). Left ventricular 
(LV) and right ventricular (RV) diameters and function were assessed by echocardiographic 
standard parameters. Longitudinal 2D strain of the LV (GLPS) and left atrium (LA) was 
determined by 2D STE. Results: After KTX, median serum creatinine level was 1.3 mg/dl 
(IQR, 1.2-1.5). Systolic blood pressure decreased significantly after KTX. Echocardiography 
showed a significant reduction in LV end-diastolic septal and posterior wall thickness and LV 
mass index after KTX, which was accompanied by an improvement of GLPS. There were no 
relevant changes in parameters of LA (reservoir, conduit or contractile) function, LV diastolic 
or RV function after KTX. Conclusion: LV hypertrophy reversed after successful KTX and was 
accompanied by an improvement in longitudinal LV function as assessed by STE. Diastolic 
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IntroductionCardiac and renal function are closely related and chronic kidney disease (CKD) represents a major risk factor for cardiovascular (CV) disease. Based on the concept of a 
cardiorenal syndrome (CRS), which was first introduced systematically in 2008, acute or chronic kidney dysfunction can cause acute or chronic heart dysfunction and vice versa [1]. CKD evokes structural and functional cardiac changes such as left ventricular hypertrophy (LVH), LV dilation, and LV systolic and diastolic dysfunction. Increased blood pressure, volume overload and in particular the uremic milieu with its toxins contribute to these 
alterations [2-4]. While cardiac changes are initially adaptive they may aggravate with 
progressing CKD, finally leading to cardiac failure. Restoration of renal function after kidney transplantation (KTX) disrupts the negative cardiorenal interplay and may reverse some of the cardiac changes seen with CKD [5, 6]. KTX was shown to reduce cardiac mortality and the 
risk for development of chronic heart failure (CHF) compared with long-term dialysis [7].Recent advances in echocardiographic methods such as tissue Doppler imaging and strain analyses by speckle tracking echocardiography (STE) allow an earlier and more sensitive detection of subtle changes of myocardial function. So far, data derived from these advanced echocardiographic modalities in KTX patients are scarce. Therefore, we evaluated changes of cardiac structure and function after KTX by advanced echocardiographic modalities.
Material and Methods 
Study design
The study comprises a retrospective analysis of a single-center prospective data base (Ethics 
Committee of the Charité-Universitätsmedizin Berlin: EA1/048/14 and EA1/330/14). The study complied 
with the Declaration of Helsinki. 469 kidney transplant recipients of the KTX Outpatient Department of 
the Charité-Universitätsmedizin Berlin, Germany who received KTX during the years 2010-2014 were screened and were included into the study when they had a comprehensive and suitable echocardiographic 
examination in our echocardiography laboratory within 210 days before kidney transplantation. Patients 
with transplant failure after KTX were excluded. Thus, thirty-one patients were included in the final analysis. 
All kidney recipients were CKD stage V according to KDIGO at the time of baseline echocardiography before 
KTX. Medical history assessment, physical examination including office blood pressure measurements with mercury sphygmomanometer (in the seated position), laboratory testing and echocardiography were 
performed before and after KTX at the follow-up visits.
Patients generally received standard immunosuppressive protocol including induction therapy (anti-
interleukin-2 receptor antibody), calcineurin inhibitor (CNI), mycophenolate and steroids. One patient 
received a CNI-free immunosuppressive regimen with belatacept. Tapering of steroids was performed 
intending steroid-free regime after the first year if no former rejection episodes had occurred.
Biochemical studiesBlood samples were collected from cubital veins before and after KTX. Standard laboratory parameters 
were obtained from EDTA blood and serum after centrifugation by established assays in the hospital’s 
laboratory. Spontaneous urinary protein excretion was quantified by turbidimetric protein assay with the 
biuret method (Labor Berlin - Charité Vivantes Services GmbH). Estimated glomerular filtration rate (eGFR) 
was calculated using the Modification of Diet in Renal Disease equation.
Echocardiography and Doppler measurementsEchocardiography was performed by experienced physicians of the echocardiography laboratory of 
the Cardiology Department, Charité-Universitätsmedizin Berlin, Germany. Echocardiographic parameters 
were obtained in the left decubitus position according to the recommendations of the American Society of 
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Dimension and Vivid E9 (GE Vingmed, Horton, Norway, M4S or M5S transducer). Three beats were stored 
digitally and analyzed offline (EchoPac PC, GE Vingmed, Horton, Norway). Cardiac dimensions were acquired 
by M-Mode echocardiography or directly from 2D images according to the recommendations of ASE and 
EACVI [8, 9]. LV mass was calculated using the Devereux formula and was indexed to the calculated body 
surface area (BSA) using the Mosteller formula [9, 10]. LV mass indices of 43-95 g/m2 for women and 49-
115 g/m2 for men were considered as normal ranges using the linear method [9]. LA volumes were obtained 
based on the recommendation of ASE and EACVI [9] and indexed to BSA. LVEF was obtained using the Auto-
EF tool (GE Vingmed, Horton, Norway) as previously described [11]. The frame rate for tissue Doppler (TDI) 
measurements was >100/s. Transmitral pw-Doppler inflow at the tips of the mitral leaflets was measured 
to obtain E wave velocity, E wave deceleration time (DT), A wave velocity and E/A ratio [12]. Average peak early diastolic velocity (E´) was obtained from the septal and lateral sides of the mitral annulus in 
the apical four-chamber view with proper pulsed-wave TDI settings. Systolic (S´) and late diastolic velocity 
(A´) as well as the isovolumic relaxation time (IVRT) were quantified using pulsed-wave TDI at the septal 
insertion site of the mitral leaflet in the apical four-chamber view. The E/E´ ratio was calculated to estimate 
LV filling pressures [13, 14]. The position of the sample volume for velocity and TDI strain measurements was manually positioned in the myocardium throughout the cardiac cycle. Tricuspid annular plane systolic 
excursion (TAPSE) was acquired by M-Mode echocardiography according to Kaul et al. [15] and longitudinal 
velocity of excursion (RV S´) was assessed by pulsed-wave TDI positioning the sample volume for velocity in 
the basal free right ventricular wall [8]. 
2D speckle tracking strain analysis
For longitudinal strain analyses of the left atrium (LA) and left ventricle (LV), standard 2D ultrasound 
images were recorded with a frame rate between 60 and 80 frames per second (fps) from the apical long 
axis, two- and four-chamber views. The recordings were digitally stored for offline analysis (EchoPac PC) 
as previously described [16-18]. Briefly, LV global longitudinal peak systolic strain (GLPS) was assessed by 
a semi-automatic algorithm for tracking of the left ventricular myocardial wall which was divided into 18 
segments [17]. LA function comprises three separate components - reservoir (for pulmonary inflow during 
ventricular systole), conduit (for passive LA emptying during early diastole) and contractile function (for 
active LA emptying in the late diastole) - which can be determined separately and specifically by strain 
analysis (see [18] and [19] for further details). LA longitudinal strain was assessed by 2D STE of the LA 
septal and lateral basal segments in the apical four-chamber view. The timing of end ventricular systole was 
defined by aortic valve closure using the aortic valve click obtained by cw-Doppler flow recordings in the LV 
outflow tract. After manual tracing of endocardial borders of the atrial septum as well as lateral and superior 
walls, the software automatically traced the region of interest. To optimize tracking, the region of interest 
width was adjusted when necessary. The trigger was put at the onset of the QRS complex. Peak positive strain (R
LA
), strain during early diastole (E
LA
) and strain during atrial contraction (A
LA











) were calculated [18, 20].
Statistical analysis Results are expressed as arithmetic mean and standard deviation (SD) or, if not normally distributed variables, as median with interquartile ranges (IQR) for continuous variables and as frequency distributions 
for dichotomous variables. Accordingly, paired T-test or Wilcoxon-test were used for comparison of 
paired observations. Categorical variables were compared with chi-squared tests. Multivariate logistic regression models using stepwise backward elimination including the variables changes in systolic blood pressure, changes in body mass index and changes in heart rate were created to identify factors that were 
independently associated with an improvement of GLPS and reduction of LV mass index. For the evaluation 
of interobserver variability, intraclass correlation coefficient was calculated using GLPS measurements from 
ten randomly selected study participants assessed by two echocardiographers. One experienced observer 
calculated GLPS on two consecutive days for analysis of the intraobserver variability. Statistical analyses 
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Results
Detailed characteristics of the 31 kidney recipients before and after KTX are shown in Table 1. Mean age at KTX was 44 years (range: 19-85 years), 11 recipients were female, 20 
received a cadaveric and 11 a living kidney donation. Underlying causes for end-stage renal disease (ESRD) were glomerulonephritis (n=15), polycystic kidney disease (n=6), other 
(n=8) and unknown (n=2). Twenty-three patients received maintenance dialysis before 
KTX with a median time on dialysis of 33.5 [10.0-72.3] months and 8 patients received 
preemptive KTX. At KTX, coronary artery disease was prevalent in n=4, peripheral artery 
disease in n=4 and diabetes mellitus in n=3 patients. None of the patients had a history of 
transient ischemic attack (TIA) or stroke. Median follow-up after KTX was 19.0 [13.0-32.0] 
months. Serum creatinine and systolic blood pressure were significantly lower after KTX 
(Table 1). At follow-up, mean eGFR was 59.6 ± 19.0 ml/min and median spontaneous urinary protein excretion was 69.0 [41.0-223.0] mg/L. 
Echocardiography
All patients had sinus rhythm at the time of echocardiographic evaluation. LV end-
diastolic septal and posterior wall thickness decreased significantly after KTX (Table 2). 
Accordingly, there was a significant reduction of LV mass index reaching normal ranges 
after KTX (Table 2). GLPS improved significantly after KTX within normal ranges, while 
the increase in LVEF did not reach statistical significance (P = 0.058) (Table 3). LV diastolic 
function parameters did not change significantly after KTX, but there was a trend (P = 0.066) 
towards a lower E/E’ ratio after KTX. LA dimensions and LA reservoir, conduit and contractile 
function did not change significantly after KTX (Table 2 and 4). There were no significant 
changes in RV parameters after KTX (Table 2 and 3). 
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We observed an association between 
pre-transplant systol-ic blood pressure and both the improvement 
of GPLS (Spearman’s 
rho: 0.482, P = 0.006) and the reduction of LV mass index (Spear-
man’s rho: 0.307, P = 
0.093) after KTX. The extent of systolic blood pressure reduction after KTX showed a 
non-significant trend for prediction of im-
provement of GLPS 
(RR 1.5, 95% confi-dence interval [CI] 
1.0-2.2, P = 0.084 per 
10 mmHg) and the reduction of LV mass 
index (RR 1.6, 95% CI 
1.0-2.6, P = 0.055 per 
10 mmHg).
Intra- and in-terobserver variabil-
ity of GLPS measure-
ments was 0.96 (95% 
CI 0.86-0.99) and 0.93 
(95% CI 0.65-0.98), re-spectively. 
Table 2. Two-di-mensional echo-c a r d i o g r a p h i c data before (pre) and after (fol-
low-up) kidney transplantation (KTX)
Table 3. Changes in echocardiographic data of left ventricular (LV) systolic and diastolic and right ventricular (RV) function before (pre) and after (fol-
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DiscussionLVH is the most commonly observed cardiac change in CKD patients, which is a result 
of multiple factors including chronic uremia (which also induces cardiac fibrosis), hemo-dynamic changes (such as systemic hypertension and volume overload) and changes in the 
inflammatory, metabolic or hormonal status [21, 22]. While LVH initially represents an adap-tion to maintain cardiac function it may become maladaptive as it progresses with continu-
ing CKD finally resulting in systolic or diastolic dysfunction, which is associated with a poor 
prognosis [23]. 
In accordance with previous studies [5, 22, 24, 25], we were able to show that restoration 
of renal function by KTX ameliorated blood pressure control after KTX and significantly 
reversed LVH. Of note, all of the investigated 31 kidney transplant recipients in the present 
study were successfully transplanted (defined as the absence of maintenance dialysis since 
the date of KTX and a significant improvement of GFR). We found that improvement of renal 
function after KTX was accompanied by a significant reduction of antihypertensive medication indicating that better hypertension control was not an independent factor contributing to 
reduction of LVH. Although not reaching statistical significance in our small cohort, levels of systolic blood pressure before KTX and the decrease in systolic blood pressure over KTX 
seem to be key determinants for the reversal in LVH in line with the findings of [22, 26]. 
In hypertensive (non-ESRD) patients under antihypertensive treatment a reduction in LV mass is directly linked to prognosis including lower rates of CV mortality, stroke, myocardial 
infarction, and all-cause mortality [27]. Improvement of LV systolic function (as determined by LVEF assessment) after KTX was shown in patients with moderately reduced LV systolic function and occurs within a 
relatively short-term follow-up after KTX [5, 28]. In the present study, most patients had preserved or mildly impaired LVEF before KTX, which might explain why we observed only 
a slight, non-significant increase in LVEF. However, LV longitudinal function as assessed 
by STE (GLPS) improved significantly after KTX. Again, reasons for the improvement of LV function after KTX are multifactorial and complementary including the removal of uremic 
toxins, reversal of LVH, hemodynamic changes and restoration of inflammation [2, 24, 26, 
29]. We observed that patients with higher systolic blood pressure before KTX benefit 
the most from transplantation in terms of improvement of GLPS. LV strain of longitudinal 
shortening as assessed by STE is predominantly influenced by subendocardial fibers. It is more suited to detect subtle changes of LV function than LVEF, which mainly depends on 
radial and circumferential deformation caused by mid-myocardial and epicardial fibers [17, 
20]. GLPS is affected by the composition of the interstitial myocardium including the extent 
of myocardial fibrosis [30] and was shown to be a robust and independent predictor for all-
cause mortality in patients with severe CKD and impaired LV function [31]. Furthermore, 
GLPS assessed after KTX was shown to be a prognostic marker for CV events [32]. The 
prognostic value of changes of GLPS over KTX on future CV events has not been evaluated so far and should be addressed in further studies.Diastolic dysfunction is frequent in patients with ESRD as a result of LVH and cardiac 
fibrosis [2]. However, in line with previous studies [22, 25] we did not detect a significant 
Table 4. Left atri-
al (LA) strain be-fore (pre) and after 
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improvement in diastolic function parameters after KTX. In contrast to both mentioned 
studies, which based their classification of diastolic function solely on the mitral inflow 
pattern, we evaluated diastolic function by complementary utilization of tissue Doppler 
analyses as currently recommended [33] and by additional assessment of STE-derived LA strain. 
LimitationsThe study comprises a sample of an ESRD population with rather low prevalence of CV 
disease, relatively low LV mass index and preserved LV function. Thus, some of our findings 
might have been more pronounced in more diseased patients and with a bigger sample size. 
Furthermore, a control group of age- and sex-matched ESRD patients not undergoing KTX with repeated echocardiographic evaluations was not included in the study protocol.
Conclusions
Within a mid-term follow-up after successful KTX, we observed a significant reversal 
of LV hypertrophy. This was accompanied by a significant improvement in longitudinal LV 
function as assessed by STE. Diastolic function and STE-derived LA function parameters 
did not change significantly after KTX. These findings highlight the dynamic interplay of the cardiorenal axis and support the application of advanced echocardiographic modalities such as STE for the evaluation of cardiac function in this patient population.
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